Ocular Adverse Effects Linked to Antibody-Drug Conjugates in Cancer Treatment: An In-Depth Analysis - Quiz - MDSpire

Ocular Adverse Effects Linked to Antibody-Drug Conjugates in Cancer Treatment: An In-Depth Analysis

  • By

  • Junxiang Zhou

  • Haoyue Wang

  • Hua Xie

  • Xinyi Xu

  • Hongtao Xiao

  • April 27, 2026

  • 0 min

Share

Original Source(s)

Ocular Adverse Effects Linked to Antibody-Drug Conjugates in Cancer Treatment: An In-Depth Analysis

  • by Junxiang Zhou, Haoyue Wang, Hua Xie, Xinyi Xu, Hongtao Xiao

  • April 27, 2026

Related Content

Beyond inhibition: harnessing the DRD2–VEGF-A feedback loop for precision anti-angiogenesis therapy in cancer

Management of toxicities from antibody – drug conjugates in breast cancer

Icaritin plus TACE improves survival in advanced HCC with macrovascular invasion: a multicenter cohort study